CRISPR Therapeutics AG (LON:0VRQ)
London · Delayed Price · Currency is GBP · Price in USD 58.89
+4.44 (8.16%)
At close: Dec 4, 2025
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of 4.07 billion as of December 5, 2025. Its market cap has increased by 28.62% in one year.
Market Cap
4.07B
Enterprise Value
2.77B
Revenue
28.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.89
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 4.07B, an increase of 801.42%. That is a compound annual growth rate of 27.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.07B | 51.61% |
| Dec 31, 2024 | 2.68B | -31.26% |
| Dec 29, 2023 | 3.90B | 47.79% |
| Dec 30, 2022 | 2.64B | -38.32% |
| Dec 31, 2021 | 4.28B | -45.95% |
| Dec 31, 2020 | 7.92B | 189.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 182.10B |
| Shell | 158.59B |
| Unilever | 110.24B |
| Rio Tinto Group | 94.53B |
| British American Tobacco p.l.c. | 93.13B |
| Rolls-Royce Holdings | 91.32B |
| GSK plc | 72.45B |